Managing Myeloma
- 2011-05-04 - The IMF Presents Video of Key Points from the International Workshop XIII, Paris -- PRWeb
- 2011-05-03 - The International Myeloma Foundation Says Major Medical Meeting in Paris Will Support New Treatment Options for Patients -IMF Business Wire
- 2011-04-28 - Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 13th International Myeloma Workshop -- PR Newswire
- 2011-04-28 - Research Report: Delayed treatment with vitamin C and N-acetyl-L: -cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.--Int J Hematol
- 2011-04-27 - More Studies Are Needed On Medications To Prevent Blood Clots In Multiple Myeloma Patients -- The Myeloma Beacon
- 2011-04-26 - In Relapsed Multiple Myeloma, Subcutaneous Bortezomib Has Big Plus--Medscape Today News
- 2011-04-26 - Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.--Lancet Oncol
- 2011-04-25 - Celgene Poised to Bounce Back After Revlimid Safety Blues --Seeking Alpha
- 2011-04-23 - The incidence of contrast-induced nephropathy (CIN) in patients with multiple myeloma with a normal creatinine level is low and correlates with β(2)-microglobulin levels.--AQJR AM J Roentgenol
- 2011-04-23 - Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney--J Am Soc Nephrol
- 2011-04-22 - Studies Aim To Improve Transplantation Response Rates In Multiple Myeloma Patients--The Myeloma Beacon
- 2011-04-21 - NEWS FLASH: Kathy Giusti, Founder and CEO of the MMRF, Named One of Time Magazine's 100 Most Influential People in the World
- 2011-04-21 - XTL seeks FDA orphan drug status for blood cancer drug
- 2011-04-21 - Veteran Chicago Reporter Derrick Blakley Returns to WBBM After Intensive Cancer Treatment
- 2011-04-20 - Myeloma Research To Be Presented At The 13th International Myeloma Workshop--The Myeloma Beacon